Gibson Dunn advises Dr. Barbara Sturm on sale of majority stake to Spanish PUIG
Frankfurt a. M. — Dr. Barbara Sturm has sold a majority stake in Barbara Sturm Molecular Cosmetics GmbH to the Spanish cosmetics company Puig. Gibson, Dunn & Crutcher LLP advised Barbara Sturm on this transaction.
The Spanish cosmetics giant Puig has acquired a substantial majority stake in the Dr. Barbara Sturm brand. The price remains confidential, but is likely to be in the seven-figure range. “We are very proud to welcome a brand of the caliber of Dr. Barbara Sturm to our house for ‘Lovebrands’,” CEO Marc Puig is quoted as saying. Her “Glow Drops” are a real bestseller. The Düsseldorf-based company, which will retain a minority stake, will remain as the responsible product developer and brand face.
The Gibson Dunn corporate team, led by New York partner Andrew M. Herman and Munich partner Dr. Ferdinand Fromholzer, included Munich partners Sonja Ruttmann and Dr. Markus Nauheim, as well as Munich associates Dr. Marcus Geiss, Maximilian Schniewind and Johannes Reul. Munich partner Kai Gesing advised on IP and antitrust issues, supported by Munich associates Christoph Jacob and Yannick Oberacker on IP and Frankfurt associate Jan Vollkammer on antitrust law. In Frankfurt, counsel Alexander Klein advised on financing aspects. London partner James Cox advised on employment law issues.
About Gibson Dunn
Gibson, Dunn & Crutcher LLP is one of the leading international law firms and is ranked among the top law firms worldwide in industry surveys and by authoritative publications. With more than 1,800 lawyers in 21 offices, the firm has a global presence in all major economic regions. Gibson Dunn’s offices are located in Abu Dhabi, Brussels, Century City, Dallas, Denver, Dubai, Frankfurt, Hong Kong, Houston, London, Los Angeles, Munich, New York, Orange County, Palo Alto, Paris, Beijing, Riyadh, San Francisco, Singapore and Washington, D.C. For more information, please visit www.gibsondunn.com.